On Monday, Agenus Inc (NASDAQ: AGEN) opened higher 3.20% from the last session, before settling in for the closing price of $5.31. Price fluctuations for AGEN have ranged from $4.41 to $23.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 98.93% annually for the last half of the decade. Company’s average yearly earnings per share was noted 21.19% at the time writing. With a float of $20.50 million, this company’s outstanding shares have now reached $21.57 million.
In an organization with 389 employees, it is important to assess its efficiency.
Agenus Inc (AGEN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Agenus Inc is 4.97%, while institutional ownership is 41.49%. The most recent insider transaction that took place on Feb 15 ’24, was worth 324,050. In this transaction an insider of this company bought 500,000 shares at a rate of $0.65, taking the stock ownership to the 625,969 shares. Before that another transaction happened on Nov 15 ’23, when Company’s Director bought 25,000 for $0.76, making the entire transaction worth $19,000. This insider now owns 124,063 shares in total.
Agenus Inc (AGEN) Performance Highlights and Predictions
#####
According to the Wall Street analysts, stocks earnings will be around 21.19% per share during the next fiscal year.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Check out the current performance indicators for Agenus Inc (AGEN). In the past quarter, the stock posted a quick ratio of 0.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.21, a number that is poised to hit -2.31 in the next quarter and is forecasted to reach -9.69 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.46 million. That was inferior than the volume of 0.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.19%. Additionally, its Average True Range was 0.47.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 7.00%, which indicates a significant decrease from 33.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.05% in the past 14 days, which was lower than the 168.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.53, while its 200-day Moving Average is $11.18. However, in the short run, Agenus Inc’s stock first resistance to watch stands at $5.76. Second resistance stands at $6.03. The third major resistance level sits at $6.26. If the price goes on to break the first support level at $5.26, it is likely to go to the next support level at $5.03. Assuming the price breaks the second support level, the third support level stands at $4.76.
Agenus Inc (NASDAQ: AGEN) Key Stats
There are currently 20,999K shares outstanding in the company with a market cap of 118.20 million. Presently, the company’s annual sales total 156,310 K according to its annual income of -245,760 K. Last quarter, the company’s sales amounted to 23,510 K and its income totaled -53,080 K.
